Applied therapeutics stock.
Financial Results. Cash and cash equivalents and short-term investments totaled $37.5 million as of September 30, 2023, compared with $30.6 million at December 31, 2022. Research and development expenses for the three months ended September 30, 2023 were $10.8 million, compared to $13.1 million for the three months ended …
Applied Therapeutics will host a conference call and webcast on Thursday, February 15, 2024, at 8:30 a.m. ET to discuss the interim analysis of govorestat for the treatment of SORD Deficiency.Complete Applied Therapeutics Inc. stock information by Barron's. View real-time APLT stock price and news, along with industry-best analysis. Applied Therapeutics stock plunges 30% on Phase 3 data for cardiac drug (NASDAQ:APLT) ...With Applied Therapeutics stock trading at $3.12 per share, the total value of Applied Therapeutics stock (market capitalization) is $240.96M. Applied Therapeutics stock was originally listed at a price of $9.40 in May 14, 2019. If you had invested in Applied Therapeutics stock at $9.40, your return over the last 4 years would have been -66.81% ...
Bears are Losing Control Over Applied Therapeutics Inc. (APLT), Here's Why It's a 'Buy' Now Zacks - Fri Sep 2, 2022 . After losing some value lately, a hammer chart pattern has been formed for Applied Therapeutics Inc. (APLT), indicating that the stock has found support. This, combined with an upward trend in earnings...The Applied Therapeutics Inc. stock price gained 43.47% on the last trading day (Friday, 16th Feb 2024), rising from $3.75 to $5.38. During the last trading day the stock fluctuated 55.67% from a day low at $3.75 to a day high of $5.83. The price has been going up and down for this period, and there has been a 78.15% gain for the last 2 …Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins an...
What is the Applied Therapeutics stock forecast? · Applied Therapeutics stock prediction for 1 year from now: $ 33.91 (505.48%) · Applied Therapeutics stock ...The current Applied Therapeutics [ APLT] share price is $5.40. The Score for APLT is 82, which is 64% above its historic median score of 50, and infers lower risk than normal. APLT is currently trading in the 80-90% percentile range relative to …
545 Fifth Avenue, Suite 1400 New York, NY 10017 212.220.9226Feb 16, 2024 · Applied Therapeutics' phase 3 INSPIRE study using govorestat for treatment of patients with SORD deficiency achieved. Read why I rate APLT stock a buy. Career Opportunities. At Applied Therapeutics, we are passionate about our mission to develop transformative treatments for patients with high unmet medical need. Applied Therapeutics is dynamic company built on the foundational values of trust, respect, empathy, creativity, quality, integrity and collaboration. Our team is exactly that – a ...Applied Therapeutics, Inc. Common Stock (APLT) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.
Applied Therapeutics, Inc. Common Stock (APLT) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.
The average one-year price target for Applied Therapeutics (NasdaqGM:APLT) has been revised to 9.44 / share. This is an increase of 20.65% from the prior estimate of 7.82 dated January 16, 2024.
Get the latest stock price, quote, news and history of Applied Therapeutics, Inc. Common Stock (APLT), a biotechnology company that develops and commercializes …NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced the pricing of its underwritten public offering of …Applied Therapeutics, Inc. (Name of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 03828A101 (CUSIP Number) ... The reporting persons are the beneficial owners of 2,604,719 shares of Common Stock of the Issuer and hold warrants to purchase 7,500,000 shares of the Issuer’s Common Stock ...Jan 5, 2024 ... Use of technology ... Applied Therapeutics shares plunged almost 35% after the biotechnology firm reported disappointing results from its Phase 3 ...Dec 8, 2023 ... Even if it's not a huge purchase, we think it was good to see that Stacy Kanter, the Independent Director of Applied Therapeutics, Inc.Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest...
As we age, it’s important to keep our minds sharp and engaged. One way to do this is by participating in crossword puzzles. Not only are they a fun and enjoyable activity, but they...APLT shares declined -10.4% the day following the earnings announcement to close at 2.07. Following its earnings release, 100 days ago, APLT stock has drifted + ...Nov 5, 2023 · Our most recent data indicates that insiders own some shares in Applied Therapeutics, Inc.. As individuals, the insiders collectively own US$9.8m worth of the US$150m company. Stock Price & Overview. 1.62K followers. $5.13 -0.18 ( -3.39%) 4:00 PM 02/21/24. NASDAQ | $USD | Pre-Market: $5.40 +0.27 (+5.26%) 7:32 AM. Summary. Ratings. Financials. …Shendelman owns 2,596,387 shares of Applied Therapeutics stock worth more than $6,958,317 as of January 10th. This net worth evaluation does not reflect any other investments that Dr. Shendelman may own. Additionally, Dr. Shendelman receives an annual salary of $813,470.00 as CEO at Applied Therapeutics. Learn More about …Applied Therapeutics will host a conference call and webcast on Thursday, February 15, 2024, at 8:30 a.m. ET to discuss the interim analysis of govorestat for the treatment of SORD Deficiency.
Why Is Applied Therapeutics (APLT) Stock Down 30% Today? InvestorPlace 21d. Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket. Benzinga 21d.
APLT - Applied Therapeutics Inc Stock Price and Quote. Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. APLT. Applied …Jan 3, 2022 · Shares of Applied Therapeutics ( APLT 2.50%), a clinical-stage biopharmaceutical company, are sliding today in response to upsetting news regarding its lead candidate. It turns out the Food and ... Applied Therapeutics (NASDAQ:APLT) stock jumped 10% in late morning trading Wednesday after the company said it has submitted applications for FDA and EU approval of its drug govorestat, also ...Applied Therapeutics (NASDAQ:APLT - Get Free Report) had its price objective raised by research analysts at Citigroup from $5.00 to $7.00 in a research note issued on Friday, Benzinga reports.The brokerage presently has a "buy" rating on the stock. Citigroup's target price would suggest a potential upside of 45.23% from the stock's …shoshana Shendelman APLT stock SEC Form 4 insiders trading. shoshana has made over 11 trades of the Applied Therapeutics stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 3,968 units of APLT stock worth $7,817 on 30 November 2023.. The largest trade he's ever made was exercising 125,000 units of …Feb 15, 2024 · Applied Therapeutics Inc APLT shares are trading higher after the company, on Thursday, released interim 12-month results from the ongoing Phase 3 INSPIRE trial, in which the primary and several ... Dec 8, 2023 ... Thinking about buying stock in Applied Therapeutics, Golden Heaven Group, Smartsheet Inc, Eneti Inc, or Hello Group? ... NEW YORK, Dec. 8, 2023 / ...NEW YORK, Jan. 21, 2020 -- Applied Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications...
545 Fifth Avenue, Suite 1400 New York, NY 10017 212.220.9226
NEW YORK, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated ...
The PE Ratio as of February 2024 (TTM) for Applied Therapeutics, Inc. ( APLT) is -4.10. According to Applied Therapeutics, Inc. ’s latest financial reports and current stock price. The company's current PE Ratio is -4.10. This represents a change of 253.73% compared to the average of -1.16 of the last 4 quarters.EAM Investors LLC purchased a new position in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 391,595 shares of the company's stock, valued at approxNEW YORK, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced it has completed its public offering of 3,152,712 …Dec 8, 2023 ... Even if it's not a huge purchase, we think it was good to see that Stacy Kanter, the Independent Director of Applied Therapeutics, Inc.Jan 4, 2024 · GreenApple78. Applied Therapeutics (NASDAQ:APLT) stock plunged 30% in post-market trading Thursday after the biotech company reported mixed results from a Phase 3 study of its drug AT-001 and said ... Applied Therapeutics stock plunges 30% on Phase 3 data for cardiac drug (NASDAQ:APLT) ...Applied Therapeutics (APLT) sotck rises as its late-stage trial for lead asset govorestat hits main goals in Sorbitol Dehydrogenase ((SORD)) Deficiency. Read more here.Applied Therapeutics Inc (APLT) Alerts. Watch. Help. Go To: Full Chart. Realtime quote and/or trades are not sourced from all markets. Fundamentals. Market Capitalization, $K …Discover historical prices for APLT stock on Yahoo Finance. View daily, weekly or monthly format back to when Applied Therapeutics, Inc. stock was issued.
Get the latest information on Applied Therapeutics Inc. (APLT), a biopharmaceutical company that develops and commercializes products for …Applied Therapeutics Inc. APLT.N. Latest Trade. 2.66 USD. 0.35. +15.15% As of Jan 10, 2024. Values delayed up to 15 minutes. Today's Range. 2.25 - 2.66. 52 …The following information was filed by Applied Therapeutics Inc. (APLT) on Thursday, March 23, 2023 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the …Thinking of buying or selling Applied Therapeutics Inc stock that's listed in a currency different from your local one? Use our international stock ticker ...Instagram:https://instagram. notepad downloadthe wedding cottagebeacon minecraftepson scan 2 download Complete Applied Therapeutics Inc. stock information by Barron's. View real-time APLT stock price and news, along with industry-best analysis. thats rough buddyghost transparent background If you need cash, aren’t happy with your investment returns or want to diversify your investments, you may have to liquidate some of your stocks. Buying and selling stocks is extre...Results of Applied Therapeutics' Phase 3 INSPIRE trial for oral govorestat (AT-007). Govorestat demonstrates significant sorbitol reduction, improving mobility and overall well-being in SORD ... h2o wireless near me Applied Therapeutics, Inc. (Name of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 03828A101 (CUSIP Number) ... The reporting persons are the beneficial owners of 2,604,719 shares of Common Stock of the Issuer and hold warrants to purchase 7,500,000 shares of the Issuer’s Common Stock ...Complete Applied Therapeutics Inc. stock information by Barron's. View real-time APLT stock price and news, along with industry-best analysis.